Clinical Trial Update: RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions. [NA]

View source ↗

Summary

A molecular screening trial (RNASARC) for soft tissue sarcomas to detect NTRK1/2/3, ROS1 or ALK gene fusions; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: Centre Leon Berard | Conditions: Soft Tissue Sarcoma, Advanced Cancer | NA | Status: ACTIVE_NOT_RECRUITING